key Products/Revenue Segments include Pharmaceutical Products, Other Operating Revenue and Export Incentives ... As on 31-12-2024, the company has a total of 100.62 Crore shares outstanding.Cadila ...

incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 67,930.56 Crore) operating in Pharmaceuticals sector. Aurobindo Pharma Ltd. key Products/Revenue Segments include ...

India plans to take away the power of state drug regulators to grant approvals to manufacture antibiotics as the country ...